These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38347781)

  • 61. MKL-1-induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA-mediated glycolysis.
    Wang J; Zhang HM; Dai ZT; Huang Y; Liu H; Chen Z; Wu Y; Liao XH
    Sci Rep; 2022 Dec; 12(1):21283. PubMed ID: 36494481
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
    Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
    [TBL] [Abstract][Full Text] [Related]  

  • 63.
    Niu Y; Liu F; Wang X; Chang Y; Song Y; Chu H; Bao S; Chen C
    Onco Targets Ther; 2021; 14():3649-3658. PubMed ID: 34113130
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Circ_MAPK9 promotes STAT3 and LDHA expression by silencing miR-642b-3p and affects the progression of hepatocellular carcinoma.
    Wang K; Lu Q; Luo Y; Yu G; Wang Z; Lin J; Tan Z; Lao Y; Liu S; Yang H
    Biol Direct; 2024 Jan; 19(1):4. PubMed ID: 38163874
    [TBL] [Abstract][Full Text] [Related]  

  • 65. KDM5A silencing transcriptionally suppresses the FXYD3-PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR-433 up-regulation.
    Ma YS; Wu TM; Qian B; Liu YS; Ding H; Fan MM; Liu JB; Yu F; Wang HM; Shi Y; Gu LP; Li L; Tian LL; Wang PY; Wang GR; Wu ZJ; Zou QF; Ling CC; Fu D
    J Cell Mol Med; 2021 Apr; 25(8):4040-4052. PubMed ID: 33621431
    [TBL] [Abstract][Full Text] [Related]  

  • 66. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
    Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
    Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Myc-Associated Zinc Finger Protein Promotes Metastasis of Papillary Thyroid Cancer.
    Zheng C; Wu H; Zhang S; Tian R; Long H; Zhang H; Guo X; Li D; Tan S; Zhu X
    Front Biosci (Landmark Ed); 2023 Aug; 28(8):162. PubMed ID: 37664917
    [TBL] [Abstract][Full Text] [Related]  

  • 68. miR-34c regulates the permeability of blood-tumor barrier via MAZ-mediated expression changes of ZO-1, occludin, and claudin-5.
    Zhao L; Wang P; Liu Y; Ma J; Xue Y
    J Cell Physiol; 2015 Mar; 230(3):716-31. PubMed ID: 25201524
    [TBL] [Abstract][Full Text] [Related]  

  • 69. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
    Guo X; Wang Y
    Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The miR-383-LDHA axis regulates cell proliferation, invasion and glycolysis in hepatocellular cancer.
    Fang Z; He L; Jia H; Huang Q; Chen D; Zhang Z
    Iran J Basic Med Sci; 2017 Feb; 20(2):187-192. PubMed ID: 28293396
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
    Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
    Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Calycosin inhibits the proliferation and metastasis of renal cell carcinoma through the MAZ/HAS2 signaling pathway.
    Zhang ZH; Yuan CY; Xu M; Wang MF; Feng T; Wang Y; Zheng SF; Zhang HL; Shi GH; Cao DL; Wang ZL; Ye DW
    Phytother Res; 2024 Aug; ():. PubMed ID: 39120474
    [TBL] [Abstract][Full Text] [Related]  

  • 73. LINC00659 Inhibits Hepatocellular Carcinoma Malignant Progression by Blocking Aerobic Glycolysis through FUS Recruitment and SLC10A1 Modulation.
    Chen B; Xu X; Wu W; Zheng K; Yu Y
    Anal Cell Pathol (Amst); 2023; 2023():5852963. PubMed ID: 37234237
    [TBL] [Abstract][Full Text] [Related]  

  • 74. FOXP2 suppresses the proliferation, invasion, and aerobic glycolysis of hepatocellular carcinoma cells by regulating the KDM5A/FBP1 axis.
    Yan L; Sun H; Chen Y; Yu X; Zhang J; Li P
    Environ Toxicol; 2024 Jan; 39(1):341-356. PubMed ID: 37713600
    [TBL] [Abstract][Full Text] [Related]  

  • 75. NEIL3 promotes cell proliferation of ccRCC via the cyclin D1-Rb-E2F1 feedback loop regulation.
    Zhang M; Jiang Y; Wang J; Yue Y; Liu W; Wang L; Li Y; Wang W; Cai H; Yang Z; Ma M; Lu S; Fan J
    DNA Repair (Amst); 2024 Jan; 133():103604. PubMed ID: 37992567
    [TBL] [Abstract][Full Text] [Related]  

  • 76. REC8 promotes tumor migration, invasion and angiogenesis by targeting the PKA pathway in hepatocellular carcinoma.
    Han J; Bai Y; Wang J; Xie XL; Li AD; Ding Q; Cui ZJ; Yin J; Jiang XY; Jiang HQ
    Clin Exp Med; 2021 Aug; 21(3):479-492. PubMed ID: 33677646
    [TBL] [Abstract][Full Text] [Related]  

  • 77. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
    Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
    BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3/nuclear factor kappa B signalling.
    Wen J; Huang Z; Wei Y; Xue L; Wang Y; Liao J; Liang J; Chen X; Chu L; Zhang B
    Cell Mol Biol Lett; 2022 Sep; 27(1):79. PubMed ID: 36138344
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2.
    Du C; Lv Z; Cao L; Ding C; Gyabaah OA; Xie H; Zhou L; Wu J; Zheng S
    J Transl Med; 2014 Sep; 12():259. PubMed ID: 25240815
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming.
    Chen Q; Wang Y; Yang L; Sun L; Wen Y; Huang Y; Gao K; Yang W; Bai F; Ling L; Zhou Z; Zhang X; Xiong J; Zhai R
    J Exp Clin Cancer Res; 2022 Jul; 41(1):229. PubMed ID: 35869499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.